Patents by Inventor Eric Diesis

Eric Diesis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6818219
    Abstract: The invention concerns a reagent for diagnosing an infection caused by a virus, characterized in that it comprises essentially a mixture consisting of (1) an immunodominant fragment of a protein of said virus comprising not more than 60 aminoacids, preferably between 20 and 30 aminoacids and (2) a mixture (called mixotope) of convergent combining peptides, derived from said immunodominant fragment, which peptides are obtained by total or partial artificial degeneration of said immunodominant fragment by systematic or partial replacement of each aminoacid by another according to an appropriate substitution matrix. The invention concerns a reagent for detecting and monitoring infections caused by the Epstein-Barr virus of EBV, which is, in particular, the causal agent of infectious mononucleose and its applications for detecting an EBV infection at any stage of the infection (primo-infection, healthy carriers and induced tumors).
    Type: Grant
    Filed: April 10, 2000
    Date of Patent: November 16, 2004
    Assignees: Institut Pasteur de Lille, Centre National de la Recherche Scientifique-CNRS
    Inventors: Denis Tranchand-Bunel, Hélène Gras-Masse, Claude Auriault, André Tartar, Eric Diesis, Brigitte Bourez